HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sulphasalazine and derivatives, natural killer activity and ulcerative colitis.

Abstract
The effects of sulphasalazine, 5-aminosalicylic acid (5-ASA), sulphapyridine and azodisalicylic acid (ADS) in vitro on the natural killer (NK) activity of peripheral blood mononuclear cells (MNC) have been examined and compared with those of the lipoxygenase inhibitor, nordihydroguaiaretic acid (NDGA) and the cyclooxygenase inhibitor, indomethacin. Sulphasalazine, sulphapyridine and ADS inhibited NK activity with 50% inhibitory concentrations (IC50) of 0.7, 2.5 and 4.0 mmol/l respectively. The effect was rapidly reversible. In contrast, 5-ASA minimally inhibited NK activity at 50 mmol/l only. NDGA potently inhibited NK activity (IC50 27 mumol/l) but this was only partly reversible in short term incubations. Indomethacin had no effect at concentrations less than those inhibiting cyclo-oxygenase activity (1-10 mumol/l) but potently and reversibly inhibited NK activity at or above 25 mumol/l. The inhibitory effects observed were unlikely to be due to direct toxicity of effector cells as 5-ASA, sulphapyridine and ADS had no effect on the viability of peripheral blood MNC, whereas NDGA and indomethacin lysed MNC only at maximal concentrations tested. Though sulphasalazine produced MNC lysis at and above 1 mmol/l, the rapid reversibility of the inhibition of NK activity at 1 mmol/l suggested that lysis of NK cells contributed little to the suppressive effect at this concentration. The disparity of the therapeutic efficacy and effects on NK activity of sulphasalazine and its derivatives in vitro may suggest that NK activity is not a major pathogenic mechanism in ulcerative colitis. Any inhibitory effect on cellular immune function of indomethacin does not necessarily reflect an effect of cyclo-oxygenase inhibition.
AuthorsP R Gibson, D P Jewell
JournalClinical science (London, England : 1979) (Clin Sci (Lond)) Vol. 69 Issue 2 Pg. 177-84 (Aug 1985) ISSN: 0143-5221 [Print] England
PMID2866061 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aminosalicylic Acids
  • Catechols
  • Lipoxygenase Inhibitors
  • Sulfasalazine
  • Mesalamine
  • Masoprocol
  • olsalazine
  • Indomethacin
  • Sulfapyridine
Topics
  • Aminosalicylic Acids (pharmacology)
  • Catechols (pharmacology)
  • Cytotoxicity, Immunologic (drug effects)
  • Humans
  • In Vitro Techniques
  • Indomethacin (pharmacology)
  • Killer Cells, Natural (drug effects)
  • Lipoxygenase Inhibitors
  • Masoprocol
  • Mesalamine
  • Monocytes (drug effects)
  • Sulfapyridine (pharmacology)
  • Sulfasalazine (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: